» Articles » PMID: 39263917

ERK1/2 Mitogen-activated Protein Kinase Dimerization is Essential for the Regulation of Cell Motility

Abstract

ERK1/2 mitogen-activated protein kinases (ERK) are key regulators of basic cellular processes, including proliferation, survival, and migration. Upon phosphorylation, ERK becomes activated and a portion of it dimerizes. The importance of ERK activation in specific cellular events is generally well documented, but the role played by dimerization is largely unknown. Here, we demonstrate that impeding ERK dimerization precludes cellular movement by interfering with the molecular machinery that executes the rearrangements of the actin cytoskeleton. We also show that a constitutively dimeric ERK mutant can drive cell motility per se, demonstrating that ERK dimerization is both necessary and sufficient for inducing cellular migration. Importantly, we unveil that the scaffold protein kinase suppressor of Ras 1 (KSR1) is a critical element for endowing external agonists, acting through tyrosine kinase receptors, with the capacity to induce ERK dimerization and, subsequently, to unleash cellular motion. In agreement, clinical data disclose that high KSR1 expression levels correlate with greater metastatic potential and adverse evolution of mammary tumors. Overall, our results portray both ERK dimerization and KSR1 as essential factors for the regulation of cell motility and mammary tumor dissemination.

References
1.
Rao C, Frodyma D, Southekal S, Svoboda R, Black A, Guda C . KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition. Elife. 2021; 10. PMC: 8195604. DOI: 10.7554/eLife.66608. View

2.
Martinez-Carpio P, Mur C, Rosel P, Navarro M . Constitutive and regulated secretion of epidermal growth factor and transforming growth factor-beta1 in MDA-MB-231 breast cancer cell line in 11-day cultures. Cell Signal. 1999; 11(10):753-7. DOI: 10.1016/s0898-6568(99)00048-0. View

3.
Zaballos M, Acuna-Ruiz A, Morante M, Riesco-Eizaguirre G, Crespo P, Santisteban P . Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer. Cell Mol Life Sci. 2022; 79(9):504. PMC: 9440884. DOI: 10.1007/s00018-022-04530-9. View

4.
Santos E, Crespo P . The RAS-ERK pathway: A route for couples. Sci Signal. 2018; 11(554). DOI: 10.1126/scisignal.aav0917. View

5.
Rodriguez J, Haydinger C, Peet D, Nguyen L, von Kriegsheim A . Asparagine Hydroxylation is a Reversible Post-translational Modification. Mol Cell Proteomics. 2020; 19(11):1777-1789. PMC: 7664127. DOI: 10.1074/mcp.RA120.002189. View